Closures for Pharmaceutical Preparations: A Review of Design and Test Considerations - The author examines the use of closures for products intended for injection. - BioPharm International

ADVERTISEMENT

Closures for Pharmaceutical Preparations: A Review of Design and Test Considerations
The author examines the use of closures for products intended for injection.


BioPharm International
Volume 25, Issue 12, pp. 32-36

QUALITY CONTROL OF CLOSURES

A number of quality control checks are required for the manufacture and release of closures. These checks include:

After the material has been mixed

  • Specific gravity, which is the ratio of the weight of the molded piece to the weight of an equal volume of water
  • Color, which can be checked against a color chart
  • Dispersion of a vulcanized sample in relation to particle size
  • Examination of the ash after burning in comparison to a reference sample
  • Hardness, which can be measured in Shore Units or an equivalent standard
  • Rheology of the compound, by conducting an examination of solids under conditions in which they respond with plastic flow rather than deforming elastically in response to an applied force. This is an assessment of the force necessary to rotate the material by 1.

An important distinction is that different materials—types of rubber and formulations—have different profile and respond in different ways.

Post-compression and molding

The material is checked for rubber thickness and evenness.

Washing process

  • During the loading of stoppers into a washer, the quality of the water should be checked for bioburden and endotoxin using compendial methods.
  • The loading of the washer should take place in a controlled environment, usually a cleanroom, with staff appropriately gowned. Unusually for a pharmaceutical process and in keeping with cleanrooms used in the electronics industry, the cleanroom may be fitted with deionization equipment in order to avoid fibers being attracted to the rubber.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines
Source: BioPharm International,
Click here